FDA finalizes Voluntary Malfunction Summary Reporting guidance - MedTech Dive

Summary

The FDA's final guidance on the Voluntary Malfunction Summary Reporting (VMSR) program allows MedTech companies to submit quarterly summaries of device malfunctions, easing monitoring and reporting burdens. AdvaMed supports clearer eligibility criteria and guidance clarifications. Tags relate to regulatory aspects and adverse event reporting.